ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.933,62
1,56%
S&P 500
6.047,15
0,81%
Dow Jones
44.782,00
-0,29%
Euro vs US Dollar
1,04844
-0,15%
Bitcoin
95.815,41
-0,05%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. MedTech Acquisition Corporation (MTAC)

  7. MedTech Acquisition Corporation (MTAC) News

MTAC

MedTech Acquisition (MTAC)

MedTech Acquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MTAC
DatumZeitQuelleÜberschriftSymbolFirma
02/08/202323h00Business WireMedTech Acquisition Corporation Adjourns Special Meeting of StockholdersNASDAQ:MTACMedTech Acquisition Corporation
27/06/202322h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MTACMedTech Acquisition Corporation
22/06/202323h07Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MTACMedTech Acquisition Corporation
15/06/202323h14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
15/06/202322h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202313h06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202313h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202313h00Business WireTriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual MeetingNASDAQ:MTACMedTech Acquisition Corporation
08/06/202313h01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
08/06/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
24/05/202322h29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MTACMedTech Acquisition Corporation
15/05/202313h01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
15/05/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/04/202323h12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202313h07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202313h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202313h00Business WireTriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver MetastasesNASDAQ:MTACMedTech Acquisition Corporation
05/04/202322h32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
05/04/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
22/03/202321h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MTACMedTech Acquisition Corporation
08/03/202322h34Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
08/03/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202313h08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202313h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202313h00Business WireTriSalus Life Sciences Appoints James Alecxih to Lead Device Technology BusinessNASDAQ:MTACMedTech Acquisition Corporation
16/02/202313h08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
16/02/202313h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
09/02/202323h29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
09/02/202315h24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
08/02/202320h11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:MTAC

Kürzlich von Ihnen besucht

USOTC
DTEGY
Deutsche Telekom (QX)
TG
MBG
MercedesBenz
CCOM
US500
US 500
NYSE
MRK
Merck
TG
NOV
Novo Nordisk
DBI
DAX
DAX
NYSE
DIS
Walt Disney
TG
DTE
Deutsche Telekom
NASDAQ
NVDA
NVIDIA
CCOM
US30
US 30
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
TG
BAYN
Bayer
FX
EURJPY
Euro vs Yen
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€